Katsuya Kawano

Oita, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Unrelated hematopoietic stem cell transplantation with post-transplant cyclophosphamide for myelodysplastic syndrome with anti-HLA antibodies

Unrelated hematopoietic stem cell transplantation with post-transplant cyclophosphamide for myelodysplastic syndrome with anti-HLA antibodies

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: August 03, 2026

Successful Treatment of Adult Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis With Etoposide Guided by Plasma Epstein-Barr Virus DNA Monitoring: A Case Report.

Successful Treatment of Adult Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis With Etoposide Guided by Plasma Epstein-Barr Virus DNA Monitoring: A Case Report.

Journal: EJHaem

Published: March 17, 2026

HLA-haploidentical allogeneic hematopoietic stem cell transplantation using FluMelTBI conditioning for an elderly patient with fulminant aplastic anemia during treatment for chronic lymphocytic leukemia

HLA-haploidentical allogeneic hematopoietic stem cell transplantation using FluMelTBI conditioning for an elderly patient with fulminant aplastic anemia during treatment for chronic lymphocytic leukemia

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: January 08, 2025

Successful complete remission after induction therapy with CPX-351 for acute myeloid leukemia with myelodysplasia-related changes accompanied by double-minute chromosomes and MYC gene amplification.

Successful complete remission after induction therapy with CPX-351 for acute myeloid leukemia with myelodysplasia-related changes accompanied by double-minute chromosomes and MYC gene amplification.

Journal: International journal of hematology

Published: July 11, 2024

Plasmablastic lymphoma presenting with plasmacytosis and polyclonal hypergammopathy

Plasmablastic lymphoma presenting with plasmacytosis and polyclonal hypergammopathy

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: March 06, 2024

Multiple myeloma with myelofibrosis at diagnosis and aggressive extramedullary relapse after autologous stem cell transplantation

Multiple myeloma with myelofibrosis at diagnosis and aggressive extramedullary relapse after autologous stem cell transplantation

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: February 04, 2024

Gilteritinib as Bridging and Posttransplant Maintenance for Relapsed Acute Myeloid Leukemia with FLT3-ITD Mutation Accompanied by Extramedullary Disease in Elderly.

Gilteritinib as Bridging and Posttransplant Maintenance for Relapsed Acute Myeloid Leukemia with FLT3-ITD Mutation Accompanied by Extramedullary Disease in Elderly.

Journal: Case reports in hematology

Published: June 01, 2023

Successful treatment with blinatumomab for acute lymphoblastic leukemia in an older adult patient complicated with hepatocarcinoma.

Successful treatment with blinatumomab for acute lymphoblastic leukemia in an older adult patient complicated with hepatocarcinoma.

Journal: Leukemia research reports

Published: January 30, 2023

Busulfan/thiotepa followed by autologous peripheral blood stem cell transplantation for refractory diffuse large B-cell lymphoma accompanied by hypopyon

Busulfan/thiotepa followed by autologous peripheral blood stem cell transplantation for refractory diffuse large B-cell lymphoma accompanied by hypopyon

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: November 09, 2022

Successful treatment with tirabrutinib for relapsed Bing-Neel syndrome following high-dose methotrexate and craniospinal irradiation.

Successful treatment with tirabrutinib for relapsed Bing-Neel syndrome following high-dose methotrexate and craniospinal irradiation.

Journal: Journal of clinical and experimental hematopathology : JCEH

Published: September 28, 2022

Successful alectinib monotherapy for residual disease after brentuximab vedotin combined chemotherapy in ALK-positive anaplastic large cell lymphoma

Successful alectinib monotherapy for residual disease after brentuximab vedotin combined chemotherapy in ALK-positive anaplastic large cell lymphoma

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: September 04, 2022

Poor clinical outcome of elderly patients with primary plasma cell leukemia treated with novel agents: real-world experience.

Poor clinical outcome of elderly patients with primary plasma cell leukemia treated with novel agents: real-world experience.

Journal: Leukemia & lymphoma

Published: June 10, 2022

Showing 1-12 of 15

Last Updated: 09/26/2026